Previous studies suggest that disease activity alone does not reliably predict hospital readmission among patients with inflammatory bowel diseases (IBDs).
Using a national database, Dr Edward Barnes described the burden of readmissions for IBD and identify modifiable risk factors.
The team performed a retrospective cohort study using 2013 data from the Nationwide Readmission Database.
|Readmission occurs frequently in patients with IBD and is costly|
|Inflammatory Bowel Diseases|
Using International Classification of Diseases, ninth Revision, Clinical Modification (ICD-9-CM) codes, the team identified adult patients with discharge diagnoses of ulcerative colitis or Crohn's disease and ascertained diagnoses of anxiety, depression, chronic pain, tobacco use, and other comorbidities during index admission.
Logistic regression was used to estimate factors associated with hospital readmission.
The researchers found that among 52,498 hospitalizations of patients with IBD, 24% were readmitted within 90 days of the index hospitalization, resulting in roughly $576 million in excess charges.
The team observed that in patients with Crohn's disease, anxiety, depression, chronic pain, and tobacco abuse were associated with a significant increase in odds of readmission.
Among patients with ulcerative colitis, the researchers found that anxiety, depression, and chronic pain were associated with a significant increase in odds of readmission.
Dr Barnes' team comments, "Readmission occurs frequently in patients with IBD and is costly."
"Anxiety, depression, and chronic pain may represent targets for interventions to prevent 90-day hospital readmission in this population."